The short answer: Choosing breast implants is not only a decision about size today. It is a decision about a medical device, its labeling and risks, follow-up and imaging, possible future surgery, and how your goals might change. Implants are not lifetime devices, but they also do not have a universal replacement date. The most useful consultation identifies the exact device and gives you a plan for monitoring and responding to symptoms.
This guide is for someone considering breast augmentation in Miami who wants to understand the long view before signing consent. It does not recommend one implant type, predict how long an implant will last, or replace the patient information for a specific product.
What decisions come before choosing an implant size?
First define the goal: more volume, a different shape, improved symmetry, or a change after pregnancy or weight fluctuation. Then discuss whether an implant is the right tool at all. Existing tissue, chest dimensions, skin, future pregnancy plans and medical history can constrain what is reasonable. Breast augmentation may also be performed by fat transfer in some circumstances; that is a different operation with different limitations, not a one-for-one substitute for every implant goal. A breast lift addresses position rather than substantial added volume.
The ASPS breast augmentation overview describes the procedure. The Method Plastic Surgery’s breast augmentation page introduces its consultation pathway; it is not a substitute for device labeling.
Why does the exact implant matter?
The FDA describes saline-filled and silicone-gel-filled implants with differences in shell, size, shape and surface. The correct discussion uses the product proposed for you, not an internet generalization about “implants.” Ask for the manufacturer name, model, surface, fill and the current patient labeling. FDA-required materials include a boxed warning, a patient decision checklist and a device card. Read them before deciding, and keep your device information for future care.
Start with the FDA’s patient overview of breast implants and decision questions. Ask the surgeon to explain any term in the labeling you do not understand.

Are implants permanent, or must they be replaced on a schedule?
Implants are not considered lifetime devices. The likelihood of complications and additional surgery can increase with time, yet an implant does not automatically require replacement after a fixed number of years. The reason for a later procedure might be rupture, capsular contracture (tight scar tissue around the implant), a change in appearance, a new health concern, or simply a change in personal preference. Some people may never want revision; others may need it sooner than expected.
Ask what symptoms would prompt assessment, which routine examinations or imaging apply to the chosen implant, and who will coordinate that follow-up if you move. The FDA’s risks and complications page explains why ongoing monitoring matters. Follow the current product labeling and individualized medical instructions; do not use a blog’s generic interval as your schedule.
Which risks deserve a direct discussion?
Commonly discussed local issues include pain, infection, changes in sensation, asymmetry, implant displacement, rupture and capsular contracture. Some complications may require further treatment or surgery. The FDA also identifies uncommon but important cancers associated with the capsule around breast implants, including breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), which has been reported more often with textured than smooth implants, and reports of other rare cancers. These risks should be explained accurately without implying that every implant or every patient has the same risk.
Some patients report systemic symptoms they associate with implants. Their causes and individual risk are not fully established. A patient with symptoms deserves clinical evaluation, not dismissal or a promise that removal will resolve them. Review the ASPS augmentation safety page alongside the FDA materials, then ask which risks are relevant to the exact device and surgical plan.
How might future screening and pregnancy affect the decision?
Tell your healthcare team and mammography facility that you have implants. Breast-cancer screening remains important; technique or additional views may be needed, and your clinicians should explain an appropriate plan. Pregnancy, breastfeeding, weight changes and aging can alter breast appearance independent of implant integrity. Neither the device nor the operation freezes the surrounding tissue in time.
If future breastfeeding is important, discuss incisions and individual uncertainty rather than assuming it will always be unaffected. If you are already pregnant or have a new breast symptom, bring that medical issue to the appropriate clinician before pursuing an aesthetic procedure.
What if you later want implants removed or changed?
Removal, replacement or a lift after removal are different discussions. The breast may not return to its pre-implant appearance after removal because skin and tissue change over time. Ask which decisions are reversible, which may leave scars or a different contour, and whether a future operation would have separate anesthesia and facility costs. A surgeon cannot promise an exact future appearance or a single lifetime pathway.

How do cost and provider verification fit in?
An initial quote should explain the implant, surgeon, anesthesia, facility and follow-up components. Future imaging or revision may add expenses; do not assume they are included or guaranteed to be needed. The Method gives personalized pricing after evaluation, not a fixed price in this article.
Verify the operating clinician’s Florida license through the Florida Department of Health and any claimed plastic-surgery board status through the American Board of Plastic Surgery. Ask where the surgery will occur and what facility credential is being claimed. These are verification questions, not assertions about a particular surgeon or facility.
Questions worth taking to consultation
- Why is an implant preferable for my goal to fat transfer, a lift, a different operation or no surgery?
- Which exact implant model and surface do you propose, and can I read its patient labeling and decision checklist?
- What is my individualized risk of capsular contracture, rupture, infection, revision and the rarer capsule-associated cancers?
- How will I monitor this implant, and who will review imaging or symptoms later?
- How could pregnancy, breastfeeding, exercise and aging change the result or future decisions?
- What would removal or replacement involve if I change my mind?
- What is included in the quote now, and which future services are separate?
Frequently asked questions
Do all implants need replacing after ten years?
No fixed replacement year applies to everyone. Implants are not lifetime devices, but a decision to remove or replace one is based on clinical findings, device information and personal goals.
Does an FDA-approved implant mean it is risk-free?
No. Approval means the device met applicable regulatory requirements for its intended use; it does not erase surgical or long-term device risks. Read the exact product’s labeling.
Can a lift avoid implant maintenance?
A lift without an implant avoids implant-specific monitoring, but it has its own scars, surgical risks and limitations. It does not provide the same increase in volume.
Is there one safest implant for every person?
No. The relevant trade-offs depend on the device, anatomy, medical history, goals and surgical plan. Ask for an individualized explanation, not a blanket ranking.
A useful next step
Bring the FDA checklist and your own priorities to a consultation about breast augmentation at The Method Plastic Surgery. If position rather than volume is the main concern, also review our augmentation-versus-lift decision guide. The right plan should remain understandable even when future monitoring and possible changes are included.
General education, not medical advice or a device recommendation. FDA, ASPS and official verification sources reviewed October 2026; individual product labeling and your clinician’s current guidance control.